Local administration of chitosan microspheres after traumatic brain injury in rats: a new challenge for cyclosporine – a delivery

References

• Hall ED, Kupina NC, Althaus JS. Peroxynitrite scavengers for the acute treatment of traumatic brain injury. Ann NY Acad Sci 1999;890:462–8.
   PubMedGoogle Scholar
• Lifshitz J, Friberg H, Neumar RW, et al. Structural and functional damage sustained by mitochondria after traumatic brain injury in the rat: evidence for differentially sensitive populations in the cortex and hippocampus. J Cereb Blood Flow Metab 2003;23(2):219–31.
   PubMedGoogle Scholar
• Tsubokawa T, Jadhav V, Solaroglu I, et al. Lecithinized superoxide dismutase improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Stroke 2007;38(3):1057–62.
   PubMedGoogle Scholar
• Diaz-Ruiz A, Rios C, Duarte I, et al. Cyclosporin-A inhibits lipid peroxidation after spinal cord injury in rats. Neurosci Lett 1999;266(1):61–4.
   PubMedGoogle Scholar
• Riess P, Bareyre FM, Saatman KE, et al. Effects of chronic, post-injury cyclosporin A administration on motor and sensorimotor function following severe, experimental traumatic brain injury. Restor Neurol Neurosci 2001;18(1):1–8.
   PubMedGoogle Scholar
• Sullivan PG, Rabchevsky AG, Hicks RR, et al. Dose–response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats. Neuroscience 2000;101(2):289–95.
   PubMed Web of Science ®Google Scholar
• Royo NC, Shimizu S, Schouten JW, Stover JF, McIntosh TK Pharmacology of traumatic brain injury. Curr Opin Pharmacol 2003;3:27–32.
   PubMed Web of Science ®Google Scholar
• Kas HS. Chitosan: properties, preparations and application to microparticulate systems. J Microencapsul 1997;14(6):689–711.
   PubMed Web of Science ®Google Scholar
• Niu X, Feng Q, Wang M, Guo X, Zheng Q. Porous nano-HA/collagen/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2. J Control Release, 2009:134(2):111–7.
   PubMed Web of Science ®Google Scholar
• Wang AH, Chen XG, Liu CS, et al. Preparation and characteristics of chitosan microspheres in different acetylation as drug carrier system. J Microencapsul 2008;24:1–10.
   Google Scholar
• Sullivan PG, Thompson MB, Scheff SW Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury. Exp Neurol 1999;160(1):226–34.
   PubMed Web of Science ®Google Scholar
• Povlishock JT, Pettus EH Traumatically induced axonal damage: evidence for enduring changes in axolemmal permeability with associated cytoskeletal change. Acta Neurochir Suppl 1996;66:81–6.
   PubMedGoogle Scholar
• Okonkwo DO, Povlishock JT An intrathecal bolus of cyclosporin A before injury preserves mitochondrial integrity and attenuates axonal disruption in traumatic brain injury. J Cereb Blood Flow Metab 1999;19(4):443–51.
   PubMedGoogle Scholar
• Okonkwo DO, Melon DE, Pellicane AJ, et al. Dose–response of cyclosporin A in attenuating traumatic axonal injury in rat. Neuroreport 2003;14(3):463–6.
   PubMedGoogle Scholar
• Signoretti S, Marmarou A, Tavazzi B, et al. The protective effect of cyclosporin A upon N-acetylaspartate and mitochondrial dysfunction following experimental diffuse traumatic brain injury. J Neurotrauma 2004;21(9):1154–67.
   PubMed Web of Science ®Google Scholar
• Bejugam NK, Uddin AN, Gayakwad SG, D'Souza MJ Formulation and evaluation of albumin microspheres and its enteric coating using a spray-dryer. J Microencapsul 2008;25(8):577–83.
   PubMed Web of Science ®Google Scholar
• Siwale RC, Oettinger CW, Balakrishna Pai S, et al. Formulation and characterization of catalase in albumin microspheres. J Microencapsul 2009;26(5):411–19.
   PubMed Web of Science ®Google Scholar
• Sun Y, Cui F, Shi K, et al. The effect of chitosan molecular weight on the characteristics of spray-dried methotrexate-loaded chitosan microspheres for nasal administration. Drug Dev Ind Pharm 2009;35(3):379–86.
   PubMed Web of Science ®Google Scholar
• Solaroglu I, Okutan O, Kaptanoglu E, Beskonakli E, Kilinc K. Increased xanthine oxidase activity after traumatic brain injury in rats. J Clin Neurosci 2005;12(3):273–5.
   PubMedGoogle Scholar
• Feeney DM, Boyeson MG, Linn RT, Murray HM, Dail WG. Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Res 1981;211(1):67–77.
   PubMed Web of Science ®Google Scholar
• Murakami K, Kondo T, Yang G, et al. Cold injury in mice: a model to study mechanisms of brain edema and neuronal apoptosis. Prog Neurobiol 1999;57(3):289–99.
   PubMedGoogle Scholar
• Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95(2):351–8.
   PubMed Web of Science ®Google Scholar
• Yildirim E, Solaroglu I, Okutan O, et al. Ultrastructural changes in tracheobronchial epithelia following experimental traumatic brain injury in rats: protective effect of erythropoietin. J Heart Lung Transplant 2004;23(12):1423–9.
   PubMedGoogle Scholar
• Ozisik K, Yildirim E, Kaplan S, et al. Ultrastructural changes of rat cardiac myocytes in a time-dependent manner after traumatic brain injury. Am J Transplant 2004;4(6):900–4.
   PubMed Web of Science ®Google Scholar
• Mazzeo AT, Alves OL, Gilman CB, et al. Brain metabolic and hemodynamic effects of cyclosporin A after human severe traumatic brain injury: a microdialysis study. Acta Neurochir (Wien) 2008;150(10):1019–31; discussion 1031.
   PubMed Web of Science ®Google Scholar
• Petit PX, Zamzami N, Vayssiere JL, et al. Implication of mitochondria in apoptosis. Mol Cell Biochem 1997;174(1–2):185–8.
   PubMed Web of Science ®Google Scholar
• Okonkwo DO, Buki A, Siman R, Povlishock JT. Cyclosporin A limits calcium-induced axonal damage following traumatic brain injury. Neuroreport 1999;10(2):353–8.
   PubMedGoogle Scholar
• Ankarcrona M, Dypbukt JM, Bonfoco E, et al. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995;15(4):961–73.
   PubMed Web of Science ®Google Scholar
• Zoratti M, Szabo I The mitochondrial permeability transition. Biochim Biophys Acta 1995;1241(2):139–76.
   PubMed Web of Science ®Google Scholar
• Halestrap AP, Davidson AM. Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem J 1990;268(1):153–60.
   PubMedGoogle Scholar
• Nicholls DG, Budd SL. Mitochondria and neuronal glutamate excitotoxicity. Biochim Biophys Acta 1998;1366(1–2):97–112.
   PubMedGoogle Scholar
• Scheff SW, Sullivan PG. Cyclosporin A significantly ameliorates cortical damage following experimental traumatic brain injury in rodents. J Neurotrauma 1999;16(9):783–92.
   PubMed Web of Science ®Google Scholar
• Solaroglu I, Okutan O, Solaroglu A, et al. Maternal treatment with propofol attenuates lipid peroxidation after transient intrauterine ischemia in the neonatal rat brain. Biol Neonate 2004;85(4):221–4.
   PubMedGoogle Scholar
• Schinder AF, Olson EC, Spitzer NC, Montal M. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J Neurosci 1996;16(19):6125–33.
   PubMedGoogle Scholar
• Ibarra A, Diaz-Ruiz A. Protective effect of cyclosporin-A in spinal cord injury: an overview. Curr Med Chem 2006;13(22):2703–10.
   PubMedGoogle Scholar
• Kahan BD. Cyclosporine. N Engl J Med 1989;321(25):1725–38.
   PubMed Web of Science ®Google Scholar
• Hughes RL. Cyclosporine-related central nervous system toxicity in cardiac transplantation. N Engl J Med 1990;323(6):420–1.
   PubMedGoogle Scholar
• Reece DE, Frei-Lahr DA, Shepherd JD, et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 1991;8(5):393–401.
   PubMedGoogle Scholar
• Almond BA, Hadba AR, Freeman ST, et al. Efficacy of mitoxantrone-loaded albumin microspheres for intratumoral chemotherapy of breast cancer. J Control Release 2003;91(1–2):147–55.
   PubMed Web of Science ®Google Scholar
• Jameela SR, Latha PG, Subramoniam A, Jayakrishnan A. Antitumour activity of mitoxantrone-loaded chitosan microspheres against Ehrlich ascites carcinoma. J Pharm Pharmacol 1996;48(7):685–8.
   PubMedGoogle Scholar